Literature DB >> 18939946

LKB1: cancer, polarity, metabolism, and now fertility.

Reuben J Shaw1.   

Abstract

The LKB1 serine/threonine kinase is a tumour suppressor responsible for the inherited familial cancer disorder Peutz-Jeghers syndrome and is inactivated in a large percentage of human lung cancers. LKB1 acts a master kinase, directly phosphorylating and activating a family of 14 AMPK (AMP-activated protein kinase)-related kinases which control cell metabolism, cell growth and cell polarity. In this issue of the Biochemical Journal, Hardie and colleagues discover an alternative splice form of LKB1 that alters the C-terminus of the protein containing a few known sites of post-translational regulation. Although widely expressed, the short isoform (LKB1(s)) is the sole splice isoform expressed in testes, and its expression peaks at the time of spermatid maturation. Male mice lacking the LKB1(s) isoform have dramatic defects in spermatozoa, resulting in sterility.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18939946      PMCID: PMC2676712          DOI: 10.1042/BJ20082023

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  19 in total

1.  LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons.

Authors:  Anthony P Barnes; Brendan N Lilley; Y Albert Pan; Lisa J Plummer; Ashton W Powell; Alexander N Raines; Joshua R Sanes; Franck Polleux
Journal:  Cell       Date:  2007-05-04       Impact factor: 41.582

2.  Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell vrowth.

Authors:  G P Sapkota; A Kieloch; J M Lizcano; S Lain; J S Arthur; M R Williams; N Morrice; M Deak; D R Alessi
Journal:  J Biol Chem       Date:  2001-01-31       Impact factor: 5.157

3.  Identification of the sucrose non-fermenting related kinase SNRK, as a novel LKB1 substrate.

Authors:  Mahaboobi Jaleel; Andrew McBride; Jose M Lizcano; Maria Deak; Rachel Toth; Nick A Morrice; Dario R Alessi
Journal:  FEBS Lett       Date:  2005-02-28       Impact factor: 4.124

4.  LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1.

Authors:  Jose M Lizcano; Olga Göransson; Rachel Toth; Maria Deak; Nick A Morrice; Jérôme Boudeau; Simon A Hawley; Lina Udd; Tomi P Mäkelä; D Grahame Hardie; Dario R Alessi
Journal:  EMBO J       Date:  2004-02-19       Impact factor: 11.598

5.  LKB1/STRAD promotes axon initiation during neuronal polarization.

Authors:  Maya Shelly; Laura Cancedda; Sarah Heilshorn; Germán Sumbre; Mu-Ming Poo
Journal:  Cell       Date:  2007-05-04       Impact factor: 41.582

6.  A role for Drosophila LKB1 in anterior-posterior axis formation and epithelial polarity.

Authors:  Sophie G Martin; Daniel St Johnston
Journal:  Nature       Date:  2003-01-23       Impact factor: 49.962

Review 7.  LKB1-dependent signaling pathways.

Authors:  Dario R Alessi; Kei Sakamoto; Jose R Bayascas
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

8.  Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade.

Authors:  Matthew J Sanders; Pascal O Grondin; Bronwyn D Hegarty; Michael A Snowden; David Carling
Journal:  Biochem J       Date:  2007-04-01       Impact factor: 3.857

9.  Co-expression of LKB1, MO25alpha and STRADalpha in bacteria yield the functional and active heterotrimeric complex.

Authors:  Dietbert Neumann; Marianne Suter; Roland Tuerk; Uwe Riek; Theo Wallimann
Journal:  Mol Biotechnol       Date:  2007-07       Impact factor: 2.860

10.  Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade.

Authors:  Simon A Hawley; Jérôme Boudeau; Jennifer L Reid; Kirsty J Mustard; Lina Udd; Tomi P Mäkelä; Dario R Alessi; D Grahame Hardie
Journal:  J Biol       Date:  2003-09-24
View more
  7 in total

1.  Differential effects of PKA-controlled CaMKK2 variants on neuronal differentiation.

Authors:  Wenguang Cao; Muhammad Sohail; Guodong Liu; Geremy A Koumbadinga; Vincent G Lobo; Jiuyong Xie
Journal:  RNA Biol       Date:  2011-11-01       Impact factor: 4.652

2.  AID-induced genotoxic stress promotes B cell differentiation in the germinal center via ATM and LKB1 signaling.

Authors:  Mara H Sherman; Ali I Kuraishy; Chetan Deshpande; Jason S Hong; Nicholas A Cacalano; Richard A Gatti; John P Manis; Michael A Damore; Matteo Pellegrini; Michael A Teitell
Journal:  Mol Cell       Date:  2010-09-24       Impact factor: 17.970

3.  Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1α.

Authors:  Brandon Faubert; Emma E Vincent; Takla Griss; Bozena Samborska; Said Izreig; Robert U Svensson; Orval A Mamer; Daina Avizonis; David B Shackelford; Reuben J Shaw; Russell G Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

Review 4.  mTOR: dissecting regulation and mechanism of action to understand human disease.

Authors:  Deborah C I Goberdhan; C A Richard Boyd
Journal:  Biochem Soc Trans       Date:  2009-02       Impact factor: 5.407

5.  Phosphorylation of serine 399 in LKB1 protein short form by protein kinase Cζ is required for its nucleocytoplasmic transport and consequent AMP-activated protein kinase (AMPK) activation.

Authors:  Huaiping Zhu; Cate M Moriasi; Miao Zhang; Yu Zhao; Ming-Hui Zou
Journal:  J Biol Chem       Date:  2013-04-23       Impact factor: 5.157

6.  Inhibition of β-Catenin Activity Abolishes LKB1 Loss-Driven Pancreatic Cystadenoma in Mice.

Authors:  Mei-Jen Hsieh; Ching-Chieh Weng; Yu-Chun Lin; Chia-Chen Wu; Li-Tzong Chen; Kuang-Hung Cheng
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

7.  Peripheral Neuropathy and Hindlimb Paralysis in a Mouse Model of Adipocyte-Specific Knockout of Lkb1.

Authors:  Yan Xiong; Jessica C Page; Naagarajan Narayanan; Chao Wang; Zhihao Jia; Feng Yue; Xine Shi; Wen Jin; Keping Hu; Meng Deng; Riyi Shi; Tizhong Shan; Gongshe Yang; Shihuan Kuang
Journal:  EBioMedicine       Date:  2017-09-21       Impact factor: 8.143

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.